Kinins	O
contribute	O
to	O
the	O
improvement	O
of	O
insulin	O
sensitivity	O
during	O
treatment	O
with	O
angiotensin	O
converting	O
enzyme	O
inhibitor	O
.	O

Although	O
angiotensin	O
converting	O
enzyme	O
inhibitors	O
and	O
alpha	O
1	O
-	O
blockers	O
have	O
been	O
reported	O
to	O
improve	O
insulin	O
sensitivity	O
,	O
their	O
mechanisms	O
of	O
action	O
have	O
not	O
been	O
elucidated	O
.	O

To	O
investigate	O
the	O
role	O
of	O
kinins	O
in	O
insulin	O
sensitivity	O
,	O
we	O
treated	O
4	O
-	O
week	O
-	O
old	O
spontaneously	O
hypertensive	O
rats	O
with	O
either	O
an	O
angiotensin	O
converting	O
enzyme	O
inhibitor	O
(	O
enalapril	O
)	O
,	O
an	O
alpha	O
1	O
-	O
blocker	O
(	O
doxazosin	O
)	O
,	O
or	O
an	O
angiotensin	O
II	O
antagonist	O
(	O
losartan	O
)	O
for	O
3	O
weeks	O
.	O

A	O
control	O
group	O
received	O
no	O
drugs	O
.	O

In	O
addition	O
,	O
18	O
rats	O
treated	O
with	O
enalapril	O
or	O
doxazosin	O
received	O
a	O
simultaneous	O
administration	O
of	O
a	O
kinin	O
antagonist	O
(	O
Hoe	O
140	O
)	O
.	O

Glucose	O
clamp	O
testing	O
was	O
performed	O
in	O
each	O
group	O
.	O

Enalapril	O
(	O
128	O
+	O
/	O
-	O
1	O
mmHg	O
)	O
and	O
doxazosin	O
(	O
132	O
+	O
/	O
-	O
2	O
mmHg	O
)	O
decreased	O
mean	O
blood	B-Organism_substance
pressure	O
compared	O
with	O
control	O
levels	O
(	O
148	O
+	O
/	O
-	O
1	O
mmHg	O
)	O
(	O
P	O
<	O
.	O
01	O
)	O
.	O

The	O
glucose	O
requirement	O
for	O
the	O
clamp	O
test	O
during	O
the	O
administration	O
of	O
enalapril	O
(	O
25	O
.	O
8	O
+	O
/	O
-	O
0	O
.	O
5	O
mg	O
/	O
kg	O
per	O
minute	O
)	O
or	O
doxazosin	O
(	O
28	O
.	O
6	O
+	O
/	O
-	O
0	O
.	O
7	O
mg	O
/	O
kg	O
per	O
minute	O
)	O
was	O
higher	O
than	O
that	O
of	O
the	O
control	O
group	O
(	O
19	O
.	O
8	O
+	O
/	O
-	O
0	O
.	O
5	O
mg	O
/	O
kg	O
per	O
minute	O
)	O
(	O
P	O
<	O
.	O
05	O
)	O
.	O

Although	O
Hoe	O
140	O
did	O
not	O
alter	O
the	O
glucose	O
requirement	O
of	O
doxazosin	O
(	O
27	O
.	O
8	O
+	O
/	O
-	O
0	O
.	O
5	O
mg	O
/	O
kg	O
per	O
minute	O
)	O
,	O
it	O
decreased	O
that	O
of	O
enalapril	O
(	O
22	O
.	O
6	O
+	O
/	O
-	O
0	O
.	O
9	O
mg	O
/	O
kg	O
per	O
minute	O
)	O
(	O
P	O
<	O
.	O
05	O
)	O
without	O
affecting	O
the	O
changes	O
in	O
mean	O
blood	B-Organism_substance
pressure	O
induced	O
by	O
enalapril	O
.	O

In	O
addition	O
,	O
losartan	O
decreased	O
mean	O
blood	B-Organism_substance
pressure	O
but	O
did	O
not	O
affect	O
the	O
glucose	O
requirement	O
.	O

Thus	O
,	O
the	O
improvement	O
in	O
insulin	O
sensitivity	O
produced	O
by	O
an	O
angiotensin	O
converting	O
enzyme	O
inhibitor	O
is	O
mostly	O
dependent	O
on	O
kinins	O
but	O
not	O
on	O
angiotensin	O
II	O
antagonism	O
,	O
and	O
an	O
alpha	O
1	O
-	O
blocker	O
improves	O
insulin	O
sensitivity	O
irrespective	O
of	O
kinins	O
.	O

